F.D.A. Panel to Vote on Whether Avandia Should Stay on Market
Wednesday, July 14, 2010 - 12:00
in Health & Medicine
After heated debate on Tuesday, panel members will decide whether Avandia, a controversial medicine made by GlaxoSmithKline, can remain on the market.